FACULTY
Neuropathic Pain: Incorporating New Consensus Guidelines into the Reality of Clinical Practice
Highlights from a Roundtable Symposium
Activity Date: July 2004  — Activity Info: Volume 4, (7B)
Goals & Objectives | Faculty | Introduction | Full Activity Content | CME Test & Evaluation (CME Expired) | Order Copy of Activity

 

Full Disclosure Policy Affecting CME Activities:
As sponsors accredited by the Accreditation Council for Continuing Medical Education (ACCME), the American Nurses' Credentialing Center (ANCC), and the American Council on Pharmacy Education (ACPE), it is the policy of Johns Hopkins University School of Medicine, The Institute for Johns Hopkins Nursing, and the University of Tennessee College of Pharmacy to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The Program Director and Participating Faculty reported the following:

PROGRAM DIRECTOR

Peter S. Staats, MD
Pain Physician
Metzger Pain Management
Shrewsbury, New Jersey
Adjunct Associate Professor
Department of Anesthesiology and Critical Care Medicine
Department of Oncology
Johns Hopkins University School of Medicine
Baltimore, Maryland
• Dr Staats reports receiving grants/research support from Elan Corporation, Medtronic, Inc, and Pfizer Inc and serving as a consultant to Advanced Neuromodulation Systems, Inc,
Elan Corporation, Johnson & Johnson, and Pfizer Inc.

PARTICIPATING FACULTY

Charles E. Argoff, MD
Director
Cohn Pain Management Center
North Shore University Hospital
Bethpage, New York
• Dr Argoff reports receiving grants/research support from Allergan Inc, Elan Corporation, Endo Pharmaceuticals, Kadmus Pharmaceuticals, Inc, and Pfizer Inc; serving as a consultant to Eli Lilly and Company, Endo Pharmaceuticals, and Kadmus Pharmaceuticals, Inc; and receiving honoraria from Allergan Inc, Elan Corporation, Endo Pharmaceuticals, and Pfizer Inc.

Randall Brewer, MD
Faculty Neuroanesthesiologist
Division of Neurosurgical Anesthesia
Duke Pain & Palliative Care Center
Duke University Medical Center
Durham, North Carolina
• Dr Brewer reports receiving grants/research support from Merck & Co, Inc; serving
as a consultant to Endo Pharmaceuticals; and receiving honoraria from Endo Pharmaceuticals and Pfizer Inc.

Yvonne D'Arcy, MS, CRNP, CNS
Pain Management Nurse Practitioner
Pain and Palliative Care Outcomes Center
Suburban Hospital
Bethesda, Maryland
• Ms D'Arcy reports serving on the speakersÕ bureau for Endo Pharmaceuticals and
Purdue Pharma LP.

Rollin M. Gallagher, MD, MPH
Pain Medicine and Rehabilitation Center
Medical College of Pennsylvania Hospital
Philadelphia, Pennsylvania
• Dr Gallagher reports receiving grants/research support from Eli Lilly and Company, Endo Pharmaceuticals, excelleRx, Inc, and Janssen Pharmaceutica; and serving as a consultant to Elan Corporation, Eli Lilly and Company, Endo Pharmaceuticals, excelleRx, Inc, Janssen Pharmaceutica,
and Pfizer Inc.

William McCarberg, MD, FABPM
Director
Chronic Pain Management Program
Kaiser Permanente
Escondido, California
• Dr McCarberg reports serving on the speakers' bureau for Endo Pharmaceutials, Janssen Pharmaceutica, Pfizer Inc, and Purdue Pharma LP.

Lori Reisner, PharmD
Associate Clinical Professor of Pharmacy
Clinical Pharmacist
School of Pharmacy
University of California
San Francisco
• Dr Reisner reports serving as a consultant to Endo Pharmaceuticals and Janssen Pharmaceutica, and receiving honoraria from Pfizer Inc.

Notice
In accordance with the ACCME Standards for Commercial Support, the audience is advised that one or more articles in this continuing medical education activity may contain reference(s) to unlabeled or unapproved uses of drugs or devices. The following faculty members have disclosed that they have referenced the following unlabeled/unapproved uses of drugs or devices:

Dr Argoff—antidepressants, anticonvulsants.
Dr Reisner—gabapentin, lidocaine, and tricyclic antidepressants.

All other faculty have indicated that they have not referenced unlabeled/unapproved uses of drugs or devices.

Advanced Studies in Medicine provides disclosure information from contributing authors, lead presenters, and participating faculty.  Advanced Studies in Medicine does not provide disclosure information from authors of abstracts and poster presentations. The reader shall be advised that these contributors may or may not maintain financial relationships with pharmaceutical companies.

     
Home | Contact Us | View Account | Need Help?